Ling Lin

Ling Lin's work experience includes:

- Director of Clinical BioAnalytics & Translational Science at Beam Therapeutics starting in 2023.

- Associate Director of Clinical BioAnalytics & Translational Science at Beam Therapeutics from 2022 to 2023.

- Senior Scientist II at Beam Therapeutics from 2019 to 2022.

- Senior Scientist at Fulcrum Therapeutics from 2016 to 2019, where they played a key role in building the R&D platform and growing the company into the clinical stage.

- Consultant at Third Rock Ventures in 2016.

- Scientist II and R&D group leader at Dana-Farber Cancer Institute/Harvard Medical School/Broad Institute from 2013 to 2016, focusing on precision medicine and biomarker discovery.

- Postdoctoral Fellow at the University of Massachusetts Medical School from 2012 to 2013.

Ling Lin earned a Doctor of Philosophy (Ph.D.) in Biomedical Sciences from UMass Chan Medical School in 2012. In 2020, Ling attended Harvard Business School Online, although no specific degree or field of study is provided.